BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35152295)

  • 1. Cytomegalovirus Viremia Predicts Postdischarge Mortality in Kenyan HIV-Exposed Uninfected Children.
    Pavlinac PB; Singa B; Huang ML; Shrestha L; Li V; Atlas HE; Diakhate MM; Brander R; Meshak L; Bogonko G; Tickell KD; McGrath CJ; Machuara IM; Ounga DO; Berkley JA; Richardson BA; John-Stewart G; Walson JL; Slyker J
    J Infect Dis; 2022 Nov; 226(9):1519-1527. PubMed ID: 35152295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital.
    Wamalwa D; Njuguna I; Maleche-Obimbo E; Begnel E; Chebet DJ; Onyango JA; Cranmer LM; Huang ML; Richardson BA; Boeckh M; John-Stewart G; Slyker J
    Clin Infect Dis; 2022 Apr; 74(7):1237-1246. PubMed ID: 34214163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.
    Garcia-Knight MA; Nduati E; Hassan AS; Nkumama I; Etyang TJ; Hajj NJ; Gambo F; Odera D; Berkley JA; Rowland-Jones SL; Urban B
    AIDS; 2017 Aug; 31(13):1809-1818. PubMed ID: 28609400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute cytomegalovirus infection in Kenyan HIV-infected infants.
    Slyker JA; Lohman-Payne BL; John-Stewart GC; Maleche-Obimbo E; Emery S; Richardson B; Dong T; Iversen AK; Mbori-Ngacha D; Overbaugh J; Emery VC; Rowland-Jones SL
    AIDS; 2009 Oct; 23(16):2173-81. PubMed ID: 19617812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants.
    Slyker JA; Lohman-Payne BL; Rowland-Jones SL; Otieno P; Maleche-Obimbo E; Richardson B; Farquhar C; Mbori-Ngacha D; Emery VC; John-Stewart GC
    AIDS; 2009 Jan; 23(1):117-24. PubMed ID: 19050393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa.
    Fielding K; Koba A; Grant AD; Charalambous S; Day J; Spak C; Wald A; Huang ML; Corey L; Churchyard GJ
    PLoS One; 2011; 6(10):e25571. PubMed ID: 22022413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Acquisition and Inflammation in Human Immunodeficiency Virus-Exposed Uninfected Zimbabwean Infants.
    Evans C; Chasekwa B; Rukobo S; Govha M; Mutasa K; Ntozini R; Humphrey JH; Prendergast AJ
    J Infect Dis; 2017 Mar; 215(5):698-702. PubMed ID: 28011912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan Africa.
    Skipper C; Schleiss MR; Bangdiwala AS; Hernandez-Alvarado N; Taseera K; Nabeta HW; Musubire AK; Lofgren SM; Wiesner DL; Rhein J; Rajasingham R; Schutz C; Meintjes G; Muzoora C; Meya DB; Boulware DR
    Clin Infect Dis; 2020 Jul; 71(3):525-531. PubMed ID: 31504335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis.
    Skipper CP; Hullsiek KH; Cresswell FV; Tadeo KK; Okirwoth M; Blackstad M; Hernandez-Alvarado N; Fernández-Alarcón C; Walukaga S; Martyn E; Ellis J; Ssebambulidde K; Tugume L; Nuwagira E; Rhein J; Meya DB; Boulware DR; Schleiss MR;
    Int J Infect Dis; 2022 Sep; 122():785-792. PubMed ID: 35843498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients.
    Camargo JF; Kimble E; Rosa R; Shimose LA; Bueno MX; Jeyakumar N; Morris MI; Abbo LM; Simkins J; Alencar MC; Benjamin C; Wieder E; Jimenez A; Beitinjaneh A; Goodman M; Byrnes JJ; Lekakis LJ; Pereira D; Komanduri KV
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):806-814. PubMed ID: 29217388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Cytomegalovirus and Epstein-Barr Virus Viremia And Human Immunodeficiency Virus DNA Levels in the Reservoir of Kenyan Infants Receiving Antiretroviral Therapy.
    Slyker JA; Guthrie B; Pankau M; Tapia K; Wamalwa D; Benki-Nugent S; Ngugi E; Huang ML; Njuguna I; Langat A; John-Stewart G; Lehman D
    J Infect Dis; 2021 Jun; 223(11):1923-1927. PubMed ID: 33064809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.
    Moraka NO; Moyo S; Mayondi G; Leidner J; Ibrahim M; Smith C; Weinberg A; Li S; Thami PK; Kammerer B; Ajibola G; Musonda R; Shapiro R; Gaseitsiwe S; Lockman S
    J Acquir Immune Defic Syndr; 2019 May; 81(1):118-124. PubMed ID: 30964806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
    Levi LI; Sharma S; Schleiss MR; Furrer H; Nixon DE; Blackstad M; Hernandez-Alvarado N; Dwyer DE; Borges AH; Lane HC; Lundgren J; Neaton JD; Molina JM;
    AIDS; 2022 Jul; 36(9):1265-1272. PubMed ID: 35442221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients.
    Tan SK; Waggoner JJ; Pinsky BA
    J Clin Virol; 2015 Aug; 69():179-83. PubMed ID: 26209403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.
    Para MF; Kalish LA; Collier AC; Murphy EL; Drew WL;
    J Infect Dis; 2001 Jun; 183(11):1673-7. PubMed ID: 11343218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, cytomegalovirus and the growth hormone axis in HIV-exposed uninfected Zimbabwean infants.
    Evans C; Chasekwa B; Rukobo S; Govha M; Mutasa K; Ntozini R; Humphrey JH; Prendergast AJ
    AIDS; 2020 Nov; 34(14):2045-2050. PubMed ID: 32773472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
    Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
    J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus viremia in HIV-exposed and HIV-unexposed infants in Malawi.
    Giuliano M; Pirillo MF; Orlando S; Luhanga R; Mphwere R; Kavalo T; Andreotti M; Amici R; Ciccacci F; Marazzi MC; Floridia M
    Acta Trop; 2023 Oct; 246():106987. PubMed ID: 37454709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus reactivation in critically ill immunocompetent patients.
    Limaye AP; Kirby KA; Rubenfeld GD; Leisenring WM; Bulger EM; Neff MJ; Gibran NS; Huang ML; Santo Hayes TK; Corey L; Boeckh M
    JAMA; 2008 Jul; 300(4):413-22. PubMed ID: 18647984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.